vTv Therapeutics (VTVT) Tops Q3 EPS by 42c

vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.58), $0.42 better than the analyst estimate of ($1.00).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• HSBC Downgrades Hermes International (RMS:FP) (HESAY) to Hold
• Edgewell stock surges on report of rejected takeover bid